|
Balance Sheet Cash Flow Statement 1640 Marengo St., 6th Fl. Los Angeles, CA 90033 CA Tel. 323-224-3900 Fax 323-224-3096 |
Type: Public
On the web:
http://www.responsegenetics.com
Employees:
47
Employee growth: 9.3%
For Response Genetics, the answer to cancer is in the genes. The life sciences company develops clinical diagnostic tests for cancer based on genetic analysis of tumor tissues. Results of these tests can predict a patient's response to chemotherapy, as well as the potential for cancer recurrence, and can help doctors determine the best course of treatment. Its two commercial ResponseDx products are sold to select medical institutions and test lung and colorectal cancer. Response Genetics makes most of its revenue by providing laboratory testing services on clinical trial specimens for the pharmaceutical industry in the US, Europe, and Japan. Customers include GlaxoSmithKline and Taiho Pharmaceutical.
Key numbers for fiscal year ending December, 2008:
Sales: $7.1M
One year growth: (8.5%)
Net income: ($9.5)M
Officers:
Chairman: Tom R. Demeester
President, CEO, and Director: Kathleen (Kathy) Danenberg
VP, CFO, and Secretary: Thomas (Tom) Stankovich
Competitors:
Clinical Data
Genomic Health
Quest Diagnostics
